Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Lior Soussan Gutman"'
Autor:
Shlomit S. Shachar, Michelle Leviov, Rinat Yerushalmi, Karen Drumea, Margarita Tokar, Lior Soussan-Gutman, Avital Bareket-Samish, Amir Sonnenblick, Noa Ben-Baruch, Ella Evron, Einav Nili Gal-Yam, Shani Paluch-Shimon, Gil Bar-Sela, Hadar Goldvaser, Salomon M. Stemmer
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-7 (2023)
Abstract Data on using the 21-gene Recurrence Score (RS) testing on second breast cancer (BC; second primary or local recurrence) are lacking. This cohort study examined patients with first and second BC, who underwent 21-gene testing both times. It
Externí odkaz:
https://doaj.org/article/3bcf6bdee0c84eafb59930d692223e0a
Autor:
Ofer Rotem, Idit Peretz, Michelle Leviov, Iryna Kuchuk, Amit Itay, Margarita Tokar, Shani Paluch-Shimon, Ofra Maimon, Rinat Yerushalmi, Karen Drumea, Ella Evron, Amir Sonnenblick, Einav Gal-Yam, Hadar Goldvaser, Yosef Samih, Rotem Merose, Avital Bareket-Samish, Lior Soussan-Gutman, Salomon M. Stemmer
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Data on adjuvant chemotherapy (CT) benefit in ER + HER2‒ early-stage breast cancer (EBC) patients with Recurrence Score (RS) 26-30 are limited. This real-world study evaluated the relationships between the RS, adjuvant treatments, and outc
Externí odkaz:
https://doaj.org/article/ee418dc5761c458bb5099fc02f2cafa0
Autor:
Or Sehayek, Waleed Kian, Amir Onn, Ronen Stoff, Hadas Gantz Sorotsky, Melanie Zemel, Jair Bar, Yulia Dudnik, Hovav Nechushtan, Yakir Rottenberg, Lior Soussan-Gutman, Addie Dvir, Laila C. Roisman, Nir Peled
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeMolecular profiling is crucial in naïve non-small cell lung cancer (NSCLC). While tissue-based analysis is challenged by turnaround time and scarcity of tissue, there is increasing demand for liquid biopsy. We aimed to analyze the use of upfr
Externí odkaz:
https://doaj.org/article/85362ec588224779aae89838b8d19a1d
Autor:
Rinat Yerushalmi, Adi Pomerantz, Ron Lewin, Shani Paluch-Shimon, Lior Soussan-Gutman, Frederick Baehner, Hillary Voet, Avital Bareket-Samish, Inbal Kedar, Yael Goldberg, Tamar Peretz-Yablonski, Luna Kadouri
Publikováno v:
Cancer Research. 83:P3-05
Background: The RS assay is a validated prognosticator/predictor of chemotherapy (CT) benefit in ER+ HER2-negative early-stage breast cancer (BC). It is offered to pts irrespective of BRCA1/2 status. We compared RS results, single-gene expression and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::560ccac2a8383ae2a799c815d715eeed
https://doi.org/10.1158/1538-7445.sabcs22-p3-05-59
https://doi.org/10.1158/1538-7445.sabcs22-p3-05-59
Autor:
Vincent A. Miller, Myles Brown, Philip Stephens, Lajos Pusztai, Steven E. Come, Stuart Schnitt, Lauren Gilmore, Tamar Rubinek, Ido Wolf, Lior Soussan-Gutman, Addie Dvir, Jeffrey S. Ross, Geoff Otto, Doron Lipson, Matthew Hawryluk, James Sun, Mirna Jarosz, Maureen T. Cronin, Justin M. Balko, Jennifer Giltnane, Carlos L. Arteaga, Henry Gómez, Massimo Cristofanilli, Jose A. Perez-Fidalgo, Jaime Ferrer-Lozano, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam, Garrett Frampton, Gilles Buchwalter, Roman Yelensky, Rinath Jeselsohn
Purpose: We undertook this study to determine the prevalence of estrogen receptor (ER) α (ESR1) mutations throughout the natural history of hormone-dependent breast cancer and to delineate the functional roles of the most commonly detected alteratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06acf2bac7a2e8a9a46fc8d4602eef28
https://doi.org/10.1158/1078-0432.c.6522539.v1
https://doi.org/10.1158/1078-0432.c.6522539.v1
Autor:
Vincent A. Miller, Myles Brown, Philip Stephens, Lajos Pusztai, Steven E. Come, Stuart Schnitt, Lauren Gilmore, Tamar Rubinek, Ido Wolf, Lior Soussan-Gutman, Addie Dvir, Jeffrey S. Ross, Geoff Otto, Doron Lipson, Matthew Hawryluk, James Sun, Mirna Jarosz, Maureen T. Cronin, Justin M. Balko, Jennifer Giltnane, Carlos L. Arteaga, Henry Gómez, Massimo Cristofanilli, Jose A. Perez-Fidalgo, Jaime Ferrer-Lozano, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam, Garrett Frampton, Gilles Buchwalter, Roman Yelensky, Rinath Jeselsohn
PDF file - 187K, Supplementary Table 1: Detailed demographic information of all patients with metastatic breast cancer, including cohorts LM+ and EM+. Supplementary Table 2: ESR1 variant sequence data details. Abbreviations: cvg, coverage, N/A, non-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::364bdf44a49cc770d75e9442bdc0d36b
https://doi.org/10.1158/1078-0432.22452653
https://doi.org/10.1158/1078-0432.22452653
Autor:
Vincent A. Miller, Myles Brown, Philip Stephens, Lajos Pusztai, Steven E. Come, Stuart Schnitt, Lauren Gilmore, Tamar Rubinek, Ido Wolf, Lior Soussan-Gutman, Addie Dvir, Jeffrey S. Ross, Geoff Otto, Doron Lipson, Matthew Hawryluk, James Sun, Mirna Jarosz, Maureen T. Cronin, Justin M. Balko, Jennifer Giltnane, Carlos L. Arteaga, Henry Gómez, Massimo Cristofanilli, Jose A. Perez-Fidalgo, Jaime Ferrer-Lozano, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam, Garrett Frampton, Gilles Buchwalter, Roman Yelensky, Rinath Jeselsohn
XLSX file - 122K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06fca6683790241c0dad42aa1f4b293c
https://doi.org/10.1158/1078-0432.22452656.v1
https://doi.org/10.1158/1078-0432.22452656.v1
Autor:
Shlomit Strulov Shachar, Michelle Leviov, Rinat Yerushalmi, Karen Drumea, Margarita Tokar, Lior Soussan-Gutman, Avital Bareket-Samish, Amir Sonnenblick, Noa Efrat Ben-Baruch, Shani Paluch-Shimon, Gil Bar Sela, Salomon M Stemmer
Publikováno v:
Cancer Research. 82:P1-08
Background: The first invasive disease-free survival event in patients (pts) with estrogen receptor (ER)+ early-stage breast cancer (BC) is often contralateral BC, as reflected in the TAILORx data. We analyzed the CHS registry to study differences in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eab60a9d4d6cb4d031d4b81d4ee61ec7
https://doi.org/10.1158/1538-7445.sabcs21-p1-08-14
https://doi.org/10.1158/1538-7445.sabcs21-p1-08-14
Autor:
Avital Bareket-Samish, Margarita Tokar, Noa Ben-Baruch, Ariel Hammerman, Lior Soussan-Gutman, Georgeta Fried, Rinat Yerushalmi, Bella Kaufman, Tamar Peretz, Amir Sonnenblick, Salomon M. Stemmer, Nicky Liebermann, Shani Paluch-Shimon, Michelle Leviov, Yousef Samih, Iryna Kuchuk, Gil Bar Sela
Publikováno v:
Cancer Research. 80:P1-10
Background: The RS assay is widely used in ER+ HER2-negative BC to guide treatment decisions. In TAILORx, RS distribution was similar in blacks vs whites and in Hispanics vs non-Hispanics. Also, TAILORx analyses revealed similar results across ethnic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f38961e67cc81ee6acfc1dc9cd361cd
https://doi.org/10.1158/1538-7445.sabcs19-p1-10-16
https://doi.org/10.1158/1538-7445.sabcs19-p1-10-16
Autor:
Nicky Liebermann, Salomon M. Stemmer, Amir Sonnenblick, Georgeta Fried, Ariel Hammerman, Iryna Kuchuk, Lior Soussan-Gutman, Rinat Yerushalmi, Shani Paluch-Shimon, Gil Bar-Sela, Margarita Tokar, Avital Bareket-Samish, Michelle Leviov, Bella Kaufman, Yousef Samih, T. Peretz-Yablonski, Noa Ben-Baruch
Publikováno v:
The Breast Journal. 26:2096-2098
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae49faa77a37e520a683ed7ad84a677e
https://doi.org/10.1111/tbj.13870
https://doi.org/10.1111/tbj.13870